Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Benitec Biopharma Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 30 | 37 | +7 |
| Shares | 19.0M | 21.9M | +2.90M (+15.2%) |
| Value | $240.2M | $290.1M | +$50.0M (+20.8%) |
New holders (10)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 250,000 | $3.25M | 0.68% |
| ExodusPoint Capital Management, LP | 83,198 | $1.08M | 0.01% |
| Longaeva Partners L.P. | 80,000 | $1.04M | 0.59% |
| Goldman Sachs Group Inc | 45,883 | $596.9K | 0.00% |
| EAM Investors, LLC | 39,330 | $511.7K | 0.09% |
| Millennium Management LLC | 32,046 | $416.9K | 0.00% |
| HRT Financial LP | 25,927 | $337.0K | 0.00% |
| SG Americas Securities, LLC | 8,458 | $110.0K | 0.00% |
| Balyasny Asset Management LLC | 2,816 | $36.6K | 0.00% |
| Acadian Asset Management LLC | 1,817 | $23.0K | 0.00% |
Sold out (3)
Institutions that held Benitec Biopharma Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| 683 Capital Management, LLC | 35,817 | $452.4K |
| Tower Research Capital LLC (TRC) | 1,099 | $13.9K |
| GWM Advisors LLC | 671 | $8.48K |